Frequently Asked Questions

What causes Tuberous Sclerosis Complex (TSC)?

A change (mutation/pathogenic varient) in the TSC1 or TSC2 gene, which normally suppress cell growth, lead to abnormal tissue and tumor growth causing Tuberous Sclerosis Complex (TSC). Only one of the genes needs to be affected for TSC to be present. The TSC1 gene is located on chromosome 9. The TSC2 gene is located on chromosome 16. TSC is autosomal dominant which means males and females  have an equal risk of having the condition.

A child can inherit TSC if either parent has it. A parent with tuberous sclerosis has a 50 percent chance of passing the condition to their children.

About one-third of people with TSC inherited the genetic condition from a parent. However, for the other two-thirds,70% the condition is "spontaneous," meaning that the change is the first time of that change in the child's family.

Sometimes it is found that a child with TSC has a parent who also has the condition but didn’t know it. If your child is diagnosed with TSC, you may want to check that you dont also have it.

If you have one child with TSC, there is an increased chance that your other children will also have the condition.

More informatio about the genetics of TSC https://www.tscalliance.org/understanding-tsc/genetics/

More information on autosomal dominant inheritance https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/autosomal-dominant-inheritance/

How common is TSC?

TSC affects approximately 1: 6,000 live births. It is estimated there are between 1-2 million people in the world living with TSC

Can it be cured?

There is no cure, but symptoms are managed with medications (like mTOR inhibitors for tumors), therapies (physical, occupational, speech), and sometimes surgery for tumors or severe epilepsy. There are international clinical consensus guidlines for the dignosis, surveillance and management of the symptoms. (See section on Diagnosis & Management)

What's the outlook?

TSC varies widely from affecting people mildly to very severely and symptoms change over time; many live full lives though some can face severe challenges. https://www.ninds.nih.gov/health-information/disorders/tuberous-sclerosis-complex

Medication Information

Medicines.ie, is Ireland’s central, regulator approved online resource of accurate information on medicines available in the Republic of Ireland.

It provides information for healthcare professionals and the public through Summary of Product Characteristics (SPCs), Patient Information Leaflets (PILs) and Educational Materials. It is owned by the Irish Pharmaceutical Healhcare Association (IPHA) and designed for easy searching and accessing crutiol drug details https://www.medicines.ie/

Where can I find more information about TSC?

There are excellent websites hosted by TSC organisaitons worldwide where you will find extensive and comprehasive information resources and direction. We highly recommend you visit them.

TSCAlliance https://www.tscalliance.org/

Tuberous Sclerosis Association UK TSA UK https://tuberous-sclerosis.org/

Tuberous Sclerosis Australia https://tsa.org.au/

Glossary

Autosomal: means traits or conditions are linked to non-sex chromosomes, affecting all genders equally, unlike sex linked traits https://www.genome.gov/genetics-glossary/Autosomal-Dominant-Disorder

https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/autosomal-dominant-inheritance/

DNA: Deoxyribonucleic Acid, is the molecule carrying genetic instructions for life, forming a double helix structure like a twisted ladder. The sequence of these bases encodes genes, which direct the building and functioning of all organisms, determining traits and passing hereditary information from parents to offspring. https://www.genome.gov/genetics-glossary/Deoxyribonucleic-Acid-DNA#:~:text=Deoxyribonucleic%20acid%20(abbreviated%20DNA)%20is,a%20protein%20or%20RNA%20molecule.

Gene: A gene is a stretch of DNA containing a sequence (instruction) with a particular function, such as to make a specific protein. https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/gene/

TSC1 gene:

List of Abbreviations

ADHD: Attention deficit hyperactivity disorder

AEDs: Anti-Epileptic Drugs

AML: Angiomyolipoma

ANP: Advanced Nurse Practitioner

ASD: Autism Spectrum Disorder

BP: Blood Pressure

CAMHS: Child and Adolescent Mental Health Services

CD: Chronic disease

COREQ Guidelines: Consolidated criteria for reporting qualitative research guidelines

cRHM: Cardiac Rhabdomyoma

CT: Computed tomography

DOH: Department of Health

ECG: Electrocardiogram

ECHO: Echocardiogram

EEG: Electroencephalogram

EEPR: Epilepsy electronic patient record

EHR: Electronic health record

ERDERA: European Rare Diseases Research Alliance

ERN: European Reference Networks (for rare and complex diseases)

ETSC: European Tuberous Sclerosis Complex Association

EU: European Union

EURODRIS: The European Organization for Rare Diseases

FDA: Food and Drug Administration

GP: General Practitioner

HCPs: Healthcare professionals

HRB: The Health Research Board

HRCT: High resolution computerised tomography

HSE: Health Service Executive (ROI)

ID: Intellectual Disability

IDS TILDA: The Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing

IQ: Intelligence quotient

IRDiRC: International Rare Disease Research Consortium

IS: Infantile Spasms

ITHACA: Intellectual disability and Congenital Malformations (ERN)

IT: Information Technology

JARDIN: Joint Action on Integration of ERNs into National Healthcare systems

LAM: Lymphangioleiomyomatosis

MDT: Multidisciplinary team

MRI: Magnetic resonance imaging

mTOR: Mammalian target of rapamycin

mTORi: mTOR inhibitors

NCD: Non-communicable diseases

NGO: Non-governmental organization

NHS: National Health Service (UK)

NORD: National Centre for Rare Diseases

OPH: Ophthalmology

PCN: Primary care network

PKD: Polycystic kidney disease

PPI: Public and Patient Involvement in research

PIL: Patient information leaflet

PNETs: Pancreatic neuroendocrine tumors

PREMS: Patient Reported Experience Outcomes

PROMS: Patient Reported Outcome Measures

QOL: Quality of life

QPS: Quality and Patient Safety

RAH: Retinal astrocytic hamartoma

RCC: Renal cell carcinoma

RCSI: Royal College of Surgeons Ireland

RD: Rare Disease

RDCTN: Rare Disease Clinical Trial Network

RDI: Rare Diseases International

ROI: Republic of Ireland

SEGA: Subependymal giant cell astrocytoma

SEN: Subependymal nodule

SUDEP: Sudden unexpected death in epilepsy

TAND: Tuberous Sclerosis Associated Neuropsychiatric disorders

TANDem: TAND consortium empowering patients through technology

TAND-L: TAND checklist (Lifelong version)

TAND-SQ: TAND checklist (Self-complete version)

TSA: Tuberous Sclerosis Association

TOSCA: TuberOus SClerosis complex registry to increase disease Awareness

TSC: Tuberous Sclerosis Complex

TSC1: Tuberous Sclerosis Complex 1

TSC2: Tuberous Sclerosis Complex 2

UK: United Kingdom

UN: United Nations

USA: United States of America

WHO: World health Organization

Yrs.: Years